• Offer for Industry
  • Young GI
  • Patients
  • Press
  • Newsletter
  • Contact us
UEG Connect
Create myUEG account
  • About
    • To landing page
      • Who we are
      • Boards, Committees & Groups
      • Governance
      • Headquarters Management
      • History
      • What we do
      • Strategic Drivers
      • Year in Review
      • Our Members
      • Specialist Member Societies
      • National Member Societies
      • UEG Community
      • UEG Associates
      • UEG Connect
      • Women in GI
      • Young GIs
      • Researchers
      • Event Calendar
  • Week
    • To landing page
      • Congress Resources
      • UEG Week Recordings ↗
      • CME Accreditation
      • Future UEG Week
      • Programme
      • Postgraduate Teaching
      • Industry
      • Supporters
  • Education
    • To landing page
      • Gutflix - Learning Platform ↗
      • Online Courses ↗
      • Mistakes in... ↗
      • UEG Podcast ↗
      • Webinars ↗
      • Summer School
      • Masterclass
      • Gut Guide
      • Career Development
      • CME in Europe
      • Supporters
  • Research
    • To landing page
      • Horizon Europe Support
      • Start-up Grant
      • Research Projects
      • HoloSurge
      • Intercept
      • InfoGut COST Action
      • White Book 2
      • Main Results
      • Full Reports
      • Materials and Presentations
  • Quality of Care
    • To landing page
      • Search Guidelines ↗
      • Non-English Guidelines
      • How to Develop Guidelines ↗
      • Quality of Care Initiatives
      • Quality Indicators
  • Public Affairs
    • To landing page
      • News
      • Focus Areas
      • Advocacy Toolbox
      • Stakeholder Collaboration
      • Digestive Health Month
      • Position Papers
      • Advocacy Bulletin
      • #EUNewsline
      • MEP Digestive Health Group
  • Publications
    • To landing page
      • Congress Publications
      • Research Publications
      • Public Affairs Publications
      • Education Publications
      • UEG Publications
      • UEG Journal ↗
      • UEG Journal Podcast ↗
  • Opportunities
    • To landing page
      • Top Abstract Prizes
      • National Scholar Award
      • Travel Grants
      • International Scholarship Awards
      • Research Prize
      • Research Fellowship
      • Lifetime Achievement Award
      • Journal Best Paper Award
      • Activities Endorsement
      • Rising Star Awards
      • Clinical Visiting Fellowships
      • Open Positions
      • Talent Pool
  • Gutflix ↗
  • Offer for Industry
  • Young GI
  • Patients
  • Press
  • Newsletter
  • Contact us
Decide on the Spot

A case of colitis

December 07, 2016 | Bjorn Rembacken

A 65-year-old man presents with a 1-week history of increasingly intense and continuous low abdominal pain that does not appear to be exacerbated by eating. The abdominal pain was preceded by exertional chest pain that settled with anti-anginal therapy prescribed by the patient’s GP. Routine blood tests are normal on admission and the patient denies taking an NSAID or paracetamol.

An abdominal CT (image A) is organised followed by a colonoscopy. The colonoscopy detects the presence of ulceration (image B) at the caecum and proximal ascending colon, but the appearance is normal elsewhere. Mucosal samples are taken.

Apart from hypertension that is managed with ramipril, the recently started anti-anginal drug nicorandil and low-dose aspirin, the patient is well and able walk several miles without shortness of breath.

Unfortunately, the patient deteriorates a couple of days later and becomes septic. A repeat abdominal CT confirms the presence of a perforation at the level of the caecum, and the patient undergoes an emergency hemi-colectomy. Analysis of the resection specimen confirms deep ulceration with a perforation at the centre of an area of ulceration (image C). 

Case Question 1

What is the most likely diagnosis?

a)     Ischaemic colitis

b)     Aspirin-induced colonic ulceration

c)     Ulceration secondary to mucosal biopsy samples taken at colonoscopy

d)     Crohn’s disease

e)     None of the above

  • Case question 1 answer and discussion
Case question 1 answer and discussion

Correct answer: e

Discussion

Nicorandil, a combined venous and arterial vasodilator, is now effectively the drug of last resort for angina. The reason is that numerous reports of ulceration affecting the skin, eyes or mucous membranes have accumulated since the drug was launched in 1994. Small apthous ulcers are said to occur in up to 5% of patients,1 but more severe, painful and deep ulceration may ensue. In the gastrointestinal tract, perforations, fistula formation and abscesses are recognised complications. Patients taking NSAIDs or steroids or who have diverticular disease are at particular risk. There is also some evidence that the risk of ulceration increases with dose and that ulceration may be precipitated by an increase in dose. The underlying mechanism by which the drug causes ulceration is unknown. 

Nicorandil-induced ulcers persist until the drug is withdrawn, although healing may take up to 6 months. In this particular case, the ulceration would probably return after surgery if nicorandil was not identified as the underlying cause. In addition to ulceration, nicorandil is contraindicated in patients with hypokalaemia, heart failure and renal impairment.

References

1. Agbo-Godeau S, et al. Association of major aphthous ulcers and nicorandil. Lancet 1998; 352: 1598–1599. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)61045-8/abstract

Social Sharing
  • About the Author
About the Author

Bjorn Rembacken is at Leeds Teaching Hospitals NHS Trust, Leeds, UK. He was born in Sweden and qualified from Leicester University in 1987. He undertook his postgraduate education in Leicester and in Leeds. His MD was dedicated to inflammatory bowel disease. Dr Rembacken was appointed Consultant Gastroenterologist, Honorary Lecturer at Leeds University and Endoscopy Training Lead in 2005. Follow Bjorn on Twitter @Bjorn_Rembacken

Comment

Please log in with your myUEG account to post comments.

Related Articles
Mistakes in...
Mistakes in newly diagnosed Crohn’s disease and how to avoid them
Press Release
Prioritising transitional care in digestive health: a UEG roadmap
Mistakes in...
Mistakes in malignancy surveillance in IBD and how to avoid them
Press Release
A call for collaborative action: Experts and patient advocates unite to advance digestive health across Europe
Latest Articles
Decide on the Spot
An elusive lesion in the colon
Decide on the Spot
A rare biopsy finding with many possible causes
Decide on the Spot
An incidental diagnosis by endoscopic ultrasound
Decide on the Spot
A not-so-black-and-white case of gastrointestinal bleeding
Get our newsletter!
Sign up with your email to receive UEG news and updates. We respect your privacy.

Headquarters Management

United European Gastroenterology

Wickenburggasse 1
1080 Vienna, Austria



T: +43 1 997 1639

UEG Week Registration

Mondial Congress & Events

Official UEG Week Registration Partner
Operngasse 20b
1040 Vienna, Austria



T: +43 1 58804 - 0

More

Imprint

Terms & Conditions

Media Policies

Privacy Policy

Change cookie-settings

Social Media

7 767 Followers

23 000 Followers

15 666 Followers

5 866 Followers

3 670 Subscribers

11 399 Subscribers

65 Subscribers

409 Subscribers

UEG copyright 2025. All rights reserved. Use of this website constitutes acceptance of the Privacy Policy and Terms & Conditions.